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dichlofluanid and related compounds with the mutants TA102 and
TA104 of Salmonella typhimurium
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Instituto de Edafología y Biología Vegetal (CSIC), Serrano 115, dpdo 28006
Madrid, Spain
A mutagenic evaluation of captan, folpet, captafol,
dichlofluanid and related compounds was carried out using
the Salnionelia/mammalian microsóme test using strains
TA102 and TA104. These strains contain A-T base pairs at
the site of the mutation in contrast to the other Salmonella
tester strains that detect mutagens damaging G-C base pairs.
In addition, the excisión repair system of the TA102 strain
is still intact. Captan and folpet were mutagenic in strain
TA104, captafol was mutagenic in strain TA102, whereas the
remaining test compounds (dichlofluanid, tetrahydro-
phthalimide and thiozolidine-4-carboxylic acid) were not
mutagenic in either strain. In conclusión, we consider it of
valué to add these two strains to those already used in the
Ames test in order to increase confidence in our ability to
detect mutagens and to shed further light on their mechanism
of action.
Introduction
Many authors have evaluated the mutagenicity of captan and other
related pesticides (folpet, captafol and dichlofluanid) using the
Salmonella/rnamrnalian microsome or Ames test. In most cases,
the tests were carried out with the strains initially described by
Ames, i.e. his G-46, TA1535, TA1530, TA1950, TA1536,
TA1537, TA1538 (Ames et al., 1973), TA98 and TA100 (Ames
et al., 1975). Captan and folpet were mutagenic in those strains
which detect base-pair substitution mutations and in those that
detect frameshift mutations (Bridges, 1975; McCann and Ames,
1975; Ficsor et al, 1977; Carere et al, 1978; de Flora, 1978;
Moriya et al., 1978; Hollstein and McCann, 1979; Rinkus and
Legator, 1979; de Hora and Boido, 1980; Shiau et al., 1981;
Waters cía/., 1982; IARC, 1983; de Flora et al., 1984; Xu
et al., 1984). With captafol and dichlofluanid, the most sensitive
strain was TA100 although the weak mutagenic effect caused by
these producís was not always observed (Shirasu et al., 1977;
Kawachi etai, 1980; Schuphan etai, 1981; Moriya etai.,
1983; Schuphan and Casida, 1983).
At present, the strains recommended by Marón and Ames
(1983) for general mutagenicity tests are TA100, TA98, TA97
and TA102. However, there is no published information on the
mutagenicity of these producís using TAI02 strain. In this sludy
we provide information on the mutagenicity of captan and folpet
in TA102 and TA104 strains. In contrast to the olher Salmonella
tester strains which detecl mutagens damaging G-C base pairs,
these strains contain A-T base pairs at the site of the mutation
and TA102 is excisión repair proficient.
Materials and methods
Chemicals
Captan, folpet, captafol and dichlofluanid were supplied by the US Environmental
Protection Agency (EPA).
Tetrahydrophthalimide (a captan metabolite) and thiazolidine-4-carboxylic acid
(related to a captan metabolite) were supplied by Fluka and Aldrich respectively.
Table I gives ñames, chemical structure, mol. wt, purity and source of chemicals
evaluated. These compounds were dissolved in dimethyl sulphoxide (DMSO)
supplied by Merck.
Methylghoxal, methyl methane sulphonate and 2-aminoanthracene (standard
mutagens) were supplied by Aldrich, Merck and Sigma respectively.
The concentration range for each tested compound was selected according to
preliminary study results.
Bacterial strains
Salmonella typhimurium strains TA102 and TA104 were obtained from Dr B.N.
Ames, University of California at Berkeley. Their genotype has been described
previously (Levin et al., 1982; Marón and Ames, 1983).
Metabolic activarían system
The supernatant of the post-mitochondrial liver fraction (S9) from Wistar rats
(250-500 g body wt) was used as metabolic activation system. A week before
rats were killed, their drinking water was made 0.1 % in sodium phenobarbital.
Immediately before the mutagenicity tests, S9 mix was prepared, i.e. S9 with
NADP and glucose-6-phosphate cofactors.
S9 and S9 mix fractions were prepared according to the method described by
Marón and Ames (1983).
Salmonella/mammalian-microsome test
The standard píate incorporation test was used (Ames el al., 1975; Marón and
Ames, 1983).
Table I.
Common ñame
Captan
Folpet
Captafol
Dichlofluanid
Tetrahydro-
thalimide
Trade
ñame
Orthocide
Phaltan
Difolatan
Euparen
Chemical ñame Chemical structure
A'-[(trichloromethyl)th¡o]-4-cyclohexene-l,2- f^C^ '•'
dicarboximide l--A^ ¿
/V-(trichloromethyl- -^
thio)phthalimide ^v
A/-[(l,l,2,2-tetrachloroethyl)thio]- -,
4-cyclohexene- 1 ,2-dicarboximide '*•*
/V-[(dichlorofluoromethyl)thio]- T
> *.'¿
y-'il:
..-'-=-
W.W-dimethyl-A'-phenylsulphamide " O
4-cyclohexene- 1,2- f^Y^-
dicarboximide ^ i '
L-thiazolidine-4- "**Vr< i
carboxylic acid V
Mol.
wt
301
297
349
333.2
151.17
133.17
Purity
99.8%
99.8%
99.7%
99%
Puré
98%
Source
EPA
1020
EPA
3660
EPA
1000
EPA
E0331
Fluka
87453
Aldrich
T 2, 750-2
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Mutagenic evaluation of pesticidcs
Table III. Mutagenic evaluation of captan with TA104
(a) Without S9 mix
Assay I
Captan
Oig/plate)
.1.25
2.5
5
10
SM
DMSO
MG
Assay IVa
Captan
Oig/plate)
2.5
5
10
20
SM
DMSO
I M G
(b) With S9
Assay IIIa
Captan
(jig/plate)
2.5
5
10
20
SM
DMSO
2-AA
R
178 ±
327 ±
668 ±
199 ±
153 ±
278 ±
5000
R
139 ±
435 ±
268 ±
46 ±
150 ±
90 ±
2300
mix
R
583 ±
595 ±
663 ±
253 ±
226 ±
259 ±
2500
101.82
18.38
96.17
72.12
66.47
43.84
12.90
23.35
93.21
6.43(s)
13.50
37.29
46.01
24.44
29.70
61.07
23.11
52.56
MI
0
0.3
2.5
0
1.8
30.8
MI
0.3
2.3
1.2
0.6
14.7
MI
1.4
1.5
1.8
0
1.1
9.9
Q
NM
NM
M*
NM/T
NM
M4+
Q
NM
NM
NM/T
T
-
NM
M4+
Q
NM
NM
NM
NM/T
NM
M3 +
V
4 X
4 X
4 X
2 x
6 x
6 x
5 x
V
10«
108
108
107
108
108
108
I07
107
<107
2 x
V
5 x
3 x
8 x
6 x
6 x
6 x
4 x
106
107
107
107
109
109
108
106
109
109
109
Assav IIa
Captan
Gig/plate)
2.5
5
10
20
SM
DMSO
MG
Assav V
Captan
(/ig/plate)
0.62
1.25
2.5
SM
DMSO
MG
Assay IVa
Captan
Otg/plate)
2.5
5
10
20
SM
DMSO
2-AA
R
1432
1904
1692
352
238
286
4500
R
675
2132
2560
306
312
4250
R
174
143
367
136
148
126
1400
± 452.55
± 108.19
± 62.22
± 90.51
± 0.71
± 0.00
± 33.94
± 12.02
± 114.55
± 11.31(s)
± 19.09
± 5.66
MI Q
4.8 M2 +
6.7 M3 +
5.9 M3+/T
0.3 NM/T
1.2 NM
17.7 M4 +
MI Q
1.2 NM
5.9 M3+
7.3 M3 +
1 NM
12.8 M4+
MI Q
0.3 NM
0.1 NM
1.6 NM
T
0.8 NM
8.6 M4+
V
3 x 108
108
<107
2 x 106
3 x 108
3 x 108
2 x 108
V
2 x 109
2 x 109
2 x 109
2 x 109
2 x 109
2 x 109
V
108
<108
<I08
<107
I08
108
108
aRevertants were counted after 5 or 6 days.
R, revertants expressed as the x ± SD; MI, mutation Índex; Q, quality; V, number of viables/mi; s, small colonies; SM, spontaneous mutation; DMSO,
mutation in response to DMSO; MG mutation in response to methylglioxal; 2-AA, mutation in response to 2-aminoanthracene.
NM, non-mutagenic (MK2.5);
M + , very weak mutagenic (MI = 2.5-3.5);
M2 + , weak mutagenic (MI = 3.6-5.5);
M3+, mutagenic (MI = 5.6-10.5);
M4+, highly mutagenic (MI > 10.5);
T, toxic effect.
To 2 mi of top agar supplemented with 0.2 mi of a 0.5 mM histidine/biotin
solution were added: 100 /¿I of the test chemical solution, 100 or 1000 ¡L\f an
ovemight culture of the tester strain (corresponding to a 14-h incubation) and
500 //I of S9 mix (containing 4% of S9). After shaking, the mixture was spread
onto a fresh or 1-week-old minimal glucose agar píate. Plates were placed in
a 37°C incubator for at least 48 h or even more, after which revertants were
counted. All the experiments were carried out in triplícate and results were
expressed as the average number of revertants per píate. For each manipularon,
negative (spontaneous reversión and mutation in response to DMSO) and positive
(response to the standard mutagen) controls were included to ensure the validity
of the test.
Most mutagens are also toxic to some extent and consequently the number of
revertants usually decreases at higher concentrations. This decrease sometimes
leads to the misinterpretation of the mutagenicity data, especially if the toxic
chemical is only weakly mutagenic. Waleh el al. (1982) developed an assay for
measuring toxicity quantitatively. They have constructed two sets of strains,
isogenic with the Ames tester strains except for their his character. One sel consists
of the his+ derivatives of the tester strains which are used for measuring the
survival of the inoculum cells after exposure to the chemical. The other set is
the stable his~ derivatives of the tester strains which are used for simulating the
background growth in the Ames mutagenicity píate test. The percentage survival
of the his+ cells in the inoculum in the presence of the 'filler cells* is used as
a measure of the toxic effect of the chemical. Lacking these two sets of strains,
we decided to determine the number of viables after treatment with the test
compound in order to obtain an approximation of its toxic effect. The procedure
is similar to that of mutagenicity. To 2 mi of top agar supplemented with 0.2
mi of a 25 mM histidine/0.5 mM biotin solution were added: 100 /il of the test
chemical solution, 100 f¡\f 10~6 or 10~5 dilution from an overnight culture
of the tester strain and 500 /il of S9 mix. After shaking, the mixture was spread
onto a nutrient agar píate. Plates were incubated at 37°C for 24 h after which
viables were counted. As in the mutagenicity test, positive and negative controls
were included to ensure the validity of the test. A test compound concentration
is considered toxic when it produces a 10% survival or less.
In order to determine the existence of a mutagenic effect caused by the test
compound and quantify it, two methods were used: (i) calculation of the mutation
Índex, and (ii) statisticai method based on leasl-squares linear regression.
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Table IV. Mutagenic evaluation of folpet with TA104
(a) Without S9 mix
Assay I
Folpet
(/ig/plate)
2.5
5
10
20
40
SM
DMSO
MG
Assay IVa
Folpet
Oig/plate)
2.5
5
10
20
SM
DMSO
MG
(b) With S9
Assay IIIa
Folpet
Oig/plate)
2.5
5
10
20
SM
DMSO
2-AA
R
580
711
726
415
267
153
278
5000
R
285
367
600
464
150
90
2300
mix
R
445
787
1083
811
226
259
2500
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
159.10
247.49
542.35
352.14
166.17
66.47
43.84
53.71
46.70
136.47
128.00
13.50
37.29
51.74
12.22
138.58
92.72
23.11
52.56
MI
2
2.8
2.9
0.9
0
1.8
30.8
MI
1.3
1.8
3.4
2.5
0.6
14.7
MI
0.8
2.3
3.6
2.4
1.1
9.9
Q
NM
M +
M*
NM/T
NM/T
NM
M4+
Q
NM
NM
M +
M+/T
NM
M4 +
Q
NM
NM
M2+
NM/T
NM
M3+
V
6 x
6 x
6 x
4 x
6 x
6 x
5 x
V
2 x
V
5 x
5 x
3 x
1.5 x
6 x
6 x
4 X
108
108
108
107
107
108
108
108
107
107
107
106
107
107
107
109
109
109
108
109
109
109
Assay IIa
Folpet
(/ig/plate)
2.5
5
10
20
SM
DMSO
MG
Assay V
Folpet
Gig/plate)
0.62
1.25
2.5
SM
DMSO
MG
Assay IVa
Folpet
Oig/plate)
2.5
5
10
20
SM
DMSO
2-AA
R
1012
1188
1272
1783 ± 474.27
238
286
4500
R
617 ± 111.01
1208 ± 101.82
1628 ± 28.28
306 ± 0.71
312 ± 0.00
4250
R
172 ± 2.83
156 ± 22.63
196 ± 8.48
142 ± 2.83
148 ± 19.09
126 ± 5.66
1400
MI Q
3 M +
3.8 M2 +
4.1 M2+
6.3 M3 + /T
1.2 NM
17.7 M4 +
MI Q
1 NM
2.9 M +
4.3 M2+
1 NM
12.8 M4""
MI Q
0.3 NM
0.2 NM
0.5 NM
0.1 NM/T
0.8 NM
8.6 M3 +
V
3 x 108
108
108
3 x 107
3 x 108
3 x 108
2 x 108
V
2 x 109
2 x 109
2 x 10"
2 x 109
2 x 109
2 x 109
V
108
108
108
<107
108
108
108
Legend as Table III.
(i) Calculation ofthe mutation índex. The mutation Índex is defmed as the ratio
between induced and spomaneous revertants (Manera, 1981).
T-C
MI =
MI = mutation Índex
T = revertants/treated píate
C = revertants/control píate
A concentration ofthe test compound is considered mutagenic when the mutation
Índex is 2.5.
(U) Stalistical method based on ¡east squares linear regression. The method used
is based on the one described by Moore and Felton (1983) and the calculations
were made following Sokal and Rohlfs model (Sokal and Rohlf, 1980). The viables
count as well as the decrease in the number of revertants give an ¡dea of the
test compound concentrations which are toxic for the bacterium and which musí
therefore be eliminated in order to avoid any mutageniciry/toxicity interaction.
At first, a model I analysis of variance (ANOVA) of data is carried out. If ANOVA
is not significant, the tested compound is considered non-mutagenic, but if ANOVA
is significant, an analysis of regression is carried out in order to prove—in the
case of significance—that there is a linear relationship between dose and response.
and then the slope is calculated and used as a measure of the mutagenic effect.
If the analysis of regression is not significant, the mutagenic effect cannot be
calculated and in this case another method would have to be used.
The mutagenic potency has been expressed as number of induced revertants/nmol
of product, taking the number of revertants from the top level of the linear parí
of dose-response curves. When there were severa! assays with the same product
and with the same strain adjusting to a Une, the assay choice always was the
assay with the greatest slope.
Finally, a two-way ANOVA with replication (Sokal and Rohlf, 1980) was used
to determine the influence of S9 mix on the mutagenic activity observed.
Resulte
TA104
Results are summarized in Table II. According to the mutation
Índex, only captan and folpet were mutagenic. Table III shows
the mutagenic evaluation of captan and Table IV that of folpet.
Four assays have been performed in the absence of S9 mix
with both compounds. The range of concentrations evaluated was
from 0.62 to 20 /ig/plate for captan, and from 0.62 to 40 /ig/plate
for folpet. In all the assays performed with both compounds, there
was a dose-related increase in mutant colonies at non-toxic doses
used. The toxic concentration of captan was 10 /ig/plate and that
470
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2600 -f
1950 - -
1300 - -
650 --
1.25 2.5
Fig. 1. Dose—effect relationship for captan with Salmonella typhimurium TA104.
1800 -f
1350 --
900 - -
450 --/
10
Fig. 2. Dose—effect relationship for folpet with Salmonella typhimurium TA104.
Assay II
Assav I
Assay IV
3.75
ug of captan per píate
Assay II
15 20
ug of folpet per píate
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500 f
375 +
250 +
125 +
0
Without S9 mix
With S9 mix
0 1.25 2.5 3.75 5
iig of captan per píate
Fig. 3. Dose-effect relationship for captan with Salmonella typhimurium TA104 corresponding to Assay IV.
600 -t
450 +
300 +
150
Without S9 mix
With S9 mix
2.5 7. 5 10
ig of folpet per píate
Fig. 4. Dose-effect relationship for folpet with Salmonella typhimurium TAI04 corresponding to Assay IV.
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Table V.
(a) 0. 1 mi
Captan
Oig/plate)
1.25
2.5
5
10
SM
DMSO
MG
Influence of the inoculum
of the ovemight culture
R
178 ± 101.82
327 ± 18.38
668 ± 96.17
199 ± 72.12
153 ± 66.47
278 ± 43.84
5000
size in the mutagenicity of captan and folpet
MI
0
0.3
2.5
0
1.8
30.8
Q
NM
NM
M +
NM/T
NM
M4 +
V
4 X 108
4 X 108
4 X 108
2 X 107
6 X 108
6 X 108
5 X 108
to TA104
Folpet
Oig/plate)
2.5
5
10
20
40
SM
DMSO
MG
R
580 ± 159.10
711 ± 247.49
726 ±542.35
415 ± 352.14
267 ± 166.17
153 ± 66.47
278 ± 43.84
5000
MI
2
2.8
2.9
0.9
0
1.8
30.8
Q
NM
M +
M +
NM/T
NM/T
NM
M4+
V
6 x 108
6 x 108
6 x 108
4 x 107
107
6 x 108
6 x 108
5 x 108
(b) 1 mi of the ovemight culture
Captan
(/íg/plate)
1.25
2.5
5
10
SM
DMSO
MG
R
1310
1448
2704
4080
540
996
15000
MI
0.6
0.8
3.2
5.7
1.8
25.9
Q
NM
NM
M +
M3+/T
-
NM
M4+
V
4 X 108
4 X 108
4 X 108
2 x 107
6 x 108
6 x 108
5 x 108
Folpet
(/ig/plate)
2.5
5
10
20
40
SM
DMSO
MG
R
1584
2496
4240
2856
3200
540
996
15000
MI
1.1
2.8
6
3.4
4.1
1.8
25.9
Q
NM
M +
M3+
M+/T
M2+/T
NM
M4+
V
6 x 108
6 x 108
6 x 108
4 x 107
107
6 x 108
6 x 108
5 x 108
Legend as Table III.
Table VI.
(a) Fresh
Captan
Oig/plate)
2.5
5
10
20
SM
DMSO
MG
Influence of the minima!
piales
R
1432 ± 452.55
1904
1692
352
238
286
4500
glucosa agar
MI
4.8
6.7
5.9
0.3
1.2
17.7
piafes used
Q
M2 +
M3+
M3+/T
NM/T
NM
M4 +
in the mutagenicity
V
3 x 108
108
<107
2 x 106
3 x 108
3 x 108
2 x 108
of captan to TA104
(b) Oíd plates
Captan
(íig/plate)
2.5
5
10
20
SM
DMSO
MG
R
624
812
284
0(s)
203
196
3200
MI
2.1
3
0.4
1
14.7
Q
NM
M +
NM/T
T
NM
M4+
V
3 x 108
108
<107
2 x 106
3 x 108
3 x 108
2 x 108
Legend as Table III.
MMS = mutation in response to methyl methane sulphonate.
of folpet was 20 /¿g/plate since these concentrations produced
a survival of < 10% in most assays. However, there was
variability probably due to differences in spontaneous reversión
and the number of bacteria plated. The higher the spontaneous
reversión, then the higher the captan- and folpet-induced rever-
sión; when spontaneous reversión was similar the higher the
number of bacteria plated, then the higher captan- and folpet-
induced reversión (Figures 1 and 2; Tables ni and IV).
Two assays have been performed in the presence of S9 mix
for both compounds and the range of concentrations evaluated
was from 2.5 to 20 /íg/plate. The toxic concentration of both
captan and folpet was 20 /xg/plate. The differences from one assay
to another again seem to be due both spontaneous reversión and
the number of bacteria plated (Tables III and IV). The mutagenic
activity of both compounds decreased in the presence of S9 mix,
so they are considered direct mutagens (Figures 3 and 4).
The influence of the inoculum size in the mutagenicity of both
captan and folpet is shown in Table V. When 1 mi of the
ovemight culture was used to perform the test, we did not get
a better mutagenic response than when 0.1 mi of the ovemight
culture was used but a clearer dose—response relationship was
observed. However, the minimum level of detection of
mutagenicity was the same, irrespective of the inoculum size.
On the other hand, when 'oíd' minimal glucose agar plates
were used to perform the test, the mutagenic effect caused by
captan decreased (Table VI).
The minimum mutagenic concentration was 1.25 ^g/plate for
both captan and folpet. A concentration range could be established
with dose —response ranging from 1.25 to 5 /íg/plate for captan
and from 1.25 to 10 ^ g/plate for folpet, the difference being due
to the higher toxicity of captan. When there were at least three
concentrations of compound that were non-toxic to bacteria, the
statistical analysis was performed on data (Table II). The
mutagenic potency calculated for the assay with the greatest slope
was established at 106.63 revertants/nmol for captan and 156.91
revertants/nmol for folpet.
473
C.Barrueco and E.dc la Peña
Xable VIL Mutagenic evaluation of captafol with TA104
(a) Without S9 mix
Assay I
Captafol R MI Q
Oíg/plate)
0.16 288 ± 57.98 0.06 NM
0.31 276 ± 69.30 0 NM
0.62 284 ± 96.17 0.03 NM/T
SM 153 ± 66.47
DMSO 278 ± 43.84 1.8 NM
MG 5000 30.8 M4+
Assay IIa
V Captafol R
Oig/plate)
6 x 108 0.16 383 ±
3 x 108 0.31 373 ±
9 x 106 0.62 414 ±
6 x 108 SM 238
6 x 108 DMSO 286
5 x 108 MG 4500
MI Q V
118.09 0.4 NM 2 x
78.94 0.4 NM 6 x
37.48 0.5 NM/T 5 x
3 x
1.2 NM 3 x
17.7 M4 + 2 x
(b) With S9 mix
Assay IIIa
Captafol R MI Q
(/¿g/plate)
108 0.16 267 ± 12.12 0.03 NM
107 0.31 215 ± 27.23 0 NM
106 0.62 255 ± 18.90 0 NM
108 SM 226 ± 23.11
108 DMSO 259 ± 52.56 1.1 NM
108 2-AA 2500 9.9 M3 +
V
5 x 109
4 x 109
7 x 108
6 x 109
6 x 109
4 x 109
Legend as Table UI.
Table VIII. Mutagenic evaluation of dichlofluanid with TA104
(a) Without S9 mix
Assay D1
Dichlofluanid R
(/ig/plate)
0.62 258 ± 11.53
1.25 306 ± 36.94
2.5 397 ± 115.31
SM 238
DMSO 286
MG 4500
MI Q V
0 NM 3 x
0.08 NM - 2 x
0.5 NM 6 x
3 x
1.2 NM 3 x
17.7 M4 + 2 x
(b) With S9 mix
Assay IIIa
Dichlofluanid
Oig/plate)
10* 0.62
108 1.25
107 2.5
108 SM
108 DMSO
108 2-AA
R MI Q
263 ± 4.16 0.02 NM
227 ± 30.61 0 NM
231 ± 26.56 0 NM
226 ± 23.11
259 ± 52.56 1.1 NM
2500 9.9 M3+
V
5 x 109
4 x 109
4 x 10'
6 x 109
6 x 109
4 x 109
Legend as Table III.
Table IX. Mutagenic evaluation of tetrahydrophthalimide with TAI 04
(a) Without S9 mix
Assay I
Tetrahydro- R MI Q
phthalimide
(>ig/plate)
80 457 =t 29.70 1.2 NM
160 413 ± 103.94 0.9 NM
SM 153 ± 66.47
DMSO 278 ± 43.84 1.8 NM
MG 5000 30.8 M4+
Assay IIa
V Tetrahydro- R
phthalimide
Og/plate)
6 x 108 80 314
6 x 108 160 373
320 259
500 238
6 x 108 SM 238
6 x 108 DMSO 286
5 x 108 MG 4500
MI Q V
± 31.18 0.1 NM 3 x
=t 48.22 0.4 NM 3 x
± 39.89 0 NM 3 x
± 87.68 0 NM 2 x
3 x
1.2 NM 3 x
17.7 M4+ 2 x
(b) With S9 mix
Assay IIIa
Tetrahydro- R MI Q
phthalimide
(ng/plate)
108 80 166 ± 48.12 0 NM
108 160 186 ± 27.78 0 NM
108 320 201 ± 20.13 0 NM
108 500 227 ± 20.43 0 NM
108 SM 226 ± 23.11
108 DMSO 259 ± 52.56 1.1 NM
108 2-AA 2500 9.9 M3 +
V
6 x 109
6 x 109
6 x 109
5 x 109
6 x 109
6 x 109
4 x 109
Legend as Table III.
The remaining chemicals were non-mutagenic according to the
mutation índex (Tables VII —X). ANO VA was not significant
in most assays. In one case, however, there was a significance
but the variations due to the dose did not adjust to a regression
line; therefore the only method used to determine the mutagenic
effect was the mutation Índex calculation which showed the
non-mutagenicity of these compounds (Table II).
As regards toxicity, the following sequence can be seen:
thiazolidine-4-carboxylic acid = tetrahydrophthalimide < folpet
< captan < dichlofluanid < captafol.
TA102
The results are summarized in Table XI. Captafol was the only
clearly mutagenic compound. Table XII shows the mutagenic
evaluation of captafol. Three concentrations were evaluated: 0.16,
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0.31 and 0.62 /¿g/plate. In the two assays without S9 mix, there
was a dose-related increase in the number of mutant colonies;
however, there were differences between assays. The lower
spontaneous reversión showed the higher captafol-induced
reversión (Figure 5). In the presence of S9 mix, the mutagenic
activity of captafol decreased, so captafol is considered a direct
mutagen (Figure 6).
The mínimum mutagenic concentration was 0.31 ¿tg/plate. A
concentration range could be established with dose-response
ranging from 0.31 to 0.62 /¿g/plate. The statistical analysis was
performed on data (Table XII) and the mutagenic potency
calculated for the assay with the greatest slope was established
at 537.64 revertants/nmol (Table XI).
The remaining chemicals were non-mutagenic according to the
mutation Índex (Tables XIII —XVII) and the variations due to
Mulagcnic evaluation of pesticides
Table X. Mutagenic evaluation of thiazolidine-4-carboxylic acid
(a) Without S9 mix
Assay Ia
Thiazolidine-4-carboxylic R MI Q V
acid 0¿g/plate)
80 370 ± 71.00 0.3 NM 3 x 108
160 350 ± 2.83 0.3 NM 3 x 108
320 341 ± 34.08 0.2 NM 3 x 108
500 332 ± 22.63 0.2 NM 2 x 108
SM 238 3 x 108
DMSO 286 1.2 NM 3 x 108
MG 4500 17.7 M4+ 2 x 108
(b) With S9 mix
Assay IIa
Thiazolidine-4-carboxylic
acid (/ig/plate)
80
160
320
500
SM
DMSO
2-AA
R MI Q V
226 0 NM 6 x 109
166 ± 41.01 0 NM 6 x 109
202 ± 31.43 0 NM 6 x 109
181 ± 12.22 0 NM 5 x 109
226 =t 23.11 6 x 109
259 ± 52.56 1.1 NM 6 x I09
2500 9.9 M3+ 4 x 109
Legend as Table III.
Table XI. Mutagenic evaluation with TA102
Captan Folpet Captafol
I U I II I
Rangeoff] - S9+ 2.5-20 2.5-20 2.5-20.2.5-20 0.16-0.62
evaluated
in /ig/plate + S9+ 2.5-20 2.5-20
Range of mutagenic
concentrations - S9 + 0.62
according to the
mutation índex + S9 +
in /ig/plate
- S9+ NS *** **
ANOVA I
+ S9 + NS ***
Regression - S9+ NS ***
analysis + S9+ NS
Slope of regression - S9+ 1039.36
line + S9 +
Mutagenic potency
in rev/nmol
Two-way ANOVA NS
with replication ***
***
I and II refer to different assays.
Revertants were counted after 6 days.
Dichlofluanid Tetrahydro- Thiazolidine-4-
II I
0.16-0.62 0.62-2.5
0.16-0.62
0.31-0.62
0.62
***
***
**
**
1617.65
774.01
537.64
##*
#**
***
phthalimide carboxylic acid
II I II I II
0.62-2.5 80-500 80-500 80-500 80-500
0.62-2.5 80-500 80-500
«» NS Ns ***
*** *
NS *
NS NS
0.17
NS NS
NS NS
*** ***
Table XII. Mutagenic evaluation of captafol with TA102
(a) Without S9 mix
Assay Ia Assay IIa
Captafol R MI Q V Captafol R
Gig/plate) Gig/plate)
0.16 341 ± 6.00 1.4 NM 107 0.16 156 ± 3.21
0.31 403 ± 96.87 1.9 NM 107 0.31 457 ± 95.00
0.62 790 ± 262.66 5.1 M2+ 5 x 106 0.62 1037 ± 103.25
SM 122 ± 6.36 107 SM 80 ± 19.52
DMSO 164 ± 8.48 1.3 NM 107 DMSO 74 ± 18.45
MMS 2704 20.7 M4+ 2 x 106 MMS 2080
MI Q V
1 NM 107
4.8 M2+ 107
12 M4+/T 106
107
0.9 NM 107
25 M4 + /T <106
(b) With S9 mix
Assay IIa
Captafol R MI Q V
Oíg/plate)
0.16 195 ± 13.05 0.3 NM 2 x 109
0.31 324 ± 112.43 1.2 NM 2 x 109
0.62 611 ± 107.04 3 M+ 5 x 108
SM 151 ± 23.43 2 x 109
DMSO 147 ± 26.50 1 NM 2 x 109
2-AA 473 2.1 NM 3 x I08
Legend as Table III.
MMS = mutation in response to methyl methane sulphonate.
the dose, if present, either did not adjust to a regression line or,
if they did, the slope was too small (Table XI) and it may be
considered that captan, folpet, dichlofluanid, tetrahydro-
phthalimide and thiazolidine-4-carboxylic acid were non-
mutagenic to TA102 under own test conditions.
As regards toxicity, the following sequence can be seen:
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1100 -f
Assay II
825 -- Assay I
550 --
275 --
.2
Fig. 5. Dose-effect relationship for captafol with Salmonella typhimurium TA102.
1100 -f
.4 ,6 .8
i^g of captafol per píate
Without S9 mix
825 --
550 --
275 --
.2 .4 .6 .8
ug of captafol per píate
Fig. 6. Dose-effect relationship for captafol with Salmonella typhimurium TAI02 corresponding lo Assay II.
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Table XIII. Mutagcnic evaluation of dichlolluamd wilh TA104
(a) Wilhoul S9 mix
Assay )''
Dichlofiuamd
(/ig/platc)
0.62
1.25
2.5
SM
DMSO
MMS
R
311 ± 2.8.1
3(1.1
17.1
122 ± 6.16
164 ± 8.4X
27(M
MI
1.2
1 . 1
0.07
1.3
20.7
0
NM
NM
NM/T
NM
M4 '
V
<107
<I07
10"
I07
i()7
2 x 10"
Assav IIa
Dichlofluanid
(^g/platc)
0.62
1.25
2.5
SM
DMSO
MMS
R
133 ±
134 ±
1(X)
80 ±
74 ±
2080
10.07
2.81
19.52
18.45
MI
0.7
0.2
0
0.9
25
Q
NM
NM
NM
NM
M4 ' /T
V
I07
I07
.1 x 10"
m7
H)7
< 10"
(b) Wilh S9 mix
Assay IIa
Dichlolluanid
(pg/pluic)
0.62
1.25
2.5
SM
DMSO
2-AA
R
181
188
106
151
147
473
± 29.28
± 48.87
± 5.66
± 23.41
± 26.50
MI
0.2
0.3
0
1
2.1
Q
NM
NM
NM/T
NM
NM
V
2 x
2 x
2 x
2 x
2 x
3 x
10"
10"
10"
10"
10"
10*
Lcgcnd as Table I I I .
MMS = niulalion in responso lo mcthyl mcthanc sulphonalc.
Table XIV. Mutag<;nic evaluation of captan wilh TAI02
(a) Wilhoul S9 mix
Assav Ia
Captan
(/jg/plate)
2.5
5
10
20
SM
DMSO
MMS
R
139
100 ±
41 ±
20 ±
122 ±
164 ±
2704
MI
0
24.75 0
l.OO(s)
13.00(s)
6.36
8.48 1.3
20.7
0
NM
NM
T
T
NM
M4*
V
I07
I07
<107
106
I07
I07
2 x 106
Assay IIJ
Caplan
(fig/plaie)
2.5
5
10
20
SM
DMSO
MMS
R
1%
199
69
37
80
74
2080
± 7.81
± 6.03
± 45.54
± 5.5 IW
± 19.52
± 18.45
MI
1.5
1.6
0
0.9
25
0
NM
NM
NM/T
T
NM
M-rr
V
107
I07
<107
10ft
I07
I07
<106
(b) Wilh S9 mix
Assay IP
Caplan
(/ig/plale)
2.5
5
10
20
SM
DMSO
2-AA
R
351 ±
186 ±
310 ±
16 ±
151 ±
147 ±
473
72.99
96.17
1 12.93
I8.15ÍS)
23.43
26.50
MI
1.3
0.2
1.1
1
2.1
Q
NM
NM
NM
T
NM
NM
V
2
2
2
5
i
•2
3
x
x
X
X
X
X
X
10"
10"
10"
I O7
10"
10"
10»
Legcnd as Table 111.
MMS = mutation in responso to methyl methane sulphonate.
Table XV . Mulagenic evaluation of folpcl with TA102
(a) Wiihout S9 mix
Assay 1a
Folpel
(fig/platc)
2.5
5
10
20
SM
DMSO
MMS
R
331
320
339
94
122
164
2704
± 89.32
± 11.31
± 94.85
± 20.50
± 6.36
± 8.48
MI
1.4
1.3
1.4
0
1.3
20.7
0
NM
NM
NM
NM/T
NM
M4*
V
I07
I07
I07
I06
107
107
2 x I06
Assav IIJ
Folpet
(/ig/platc)
2.5
5
10
20
SM
DMSO
MMS
R
208 ±
225 ±
243 ±
152 ±
80 ±
74 ±
2080
2.00
30.00
60.14
18.33
19.52
18.45
MI
1.7
1.9
2.1
1
0.9
25
Q
NM
NM
NM
NM/T
NM
M4*/T
V
I07
107
JO7
2 x I06
107
107
<106
(b) With S9 mix
Assay IIJ
Folpet
(fíg/plale)
2.5
5
10
20
SM
DMSO
2-AA
R
271 ±
185 ±
198 ±
251 ±
151 ±
147 ±
473
24.44
30.55
12.16
14.05
23.43
26.50
MI
0.8
0.2
0.3
0.7
1
2.1
Q
NM
NM
NM
V
2 x 10"
2 x 10"
2 x 10"
NM/T2 x 10*
NM
NM
2 x 109
2 x 10"
3 x 10"
Lcgend as Table III .
MMS = mutation in responso lo mcthyl mcthanc sulphonalo.
thiazolidine^-carboxylic acid = tetrahydrophthalimide <
< captan < dichlofluanid < captafol.
folpet
Di.scussion
Thrce of the compounds evaluated showed mutagenic activity
with TAI04 and TAI02 strains. Thcse were captan and folpet
with TA104 and captafol with TA102. S9 mix decrcased the
mutagenic activity of thcsc compounds and the results obtained
confirm those obtained by differcnt aulhors for captan (Ficsor
el al., 1977; Shirasu el al., 1977; Carcre et al., 1978; de Flora,
1978; Moñyaeíal., 1978, 1983; Schuphan et al., 1981; Shiau
ct al., 1981; IARC, 1983; Schuphan and Casida, 1983; de Flora
el al., 1984j and for folpet (Shirasu et al., 1977; Moriya el al..
1978, 1983; Shiau et al., 1981; Schuphan and Casida, 1983) in the
Salmonella/mammalian microsome test and for captafol (Shirase
el ai, 1977; Moriya et al., 1983) in the test carried out with
Escherichia coli. The remaining compounds—dichlofluanid,
tetrahydrophthalimidc and thiazolidine-4-carboxylic acid—were
non-mutagenic with these strains.
In all the assays performed with a mutagenic compound, there
was a dose-relatcd increase in the numbcr of mutant colonies.
However, there were differences from one assay to another.
Many factors can have an influence on these differences (Grafe
et al., 1981; Friederich and Würgler, 1983; Anderson el al.,
1984). In this case, the main tactors seem to be the spontaneous
reversión and the number oí bacteria plated.
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Table XVI. Mulagenic evaluation of tetrahydrophlhalimide wiih
(a) Wilhout S9 mix
Assay Ia
Tetrahydro- R
phthalimide
(^g/plale)
80
160
320
500
SM
DMSO
MMS
247
269
285
300
122
164
2704
± 25.46
± 51.78
± 58.69
± 7.07
± 6.36
± 8.46
MI
0.7
0.8
1
l.l
1.3
20.7
0
NM
NM
NM
NM
NM
M4*
V
107
I07
107
<107
107
107
2 x 106
Assay IIa
TAI 02
(b) With S9 mix
Assay IP
Tetrahydro- R
phthalimide
(/ig/plate)
80
160
320
500
SM
DMSO
MMS
101 ± 36.02
129 ± 33.17
118 ± 8.72
100 ± 12.02
80 ± 19.52
74 ± 18.45
2080
MI
0.3
0.7
0.5
0.3
0.9
25
0
NM
NM
NM
NM
NM
M4 + /T
V
I07
I07
107
I07
I07
107
<106
Tetrahydro- R
phthalimide
(pg/plale)
80
160
320
500
SM
DMSO
?-AA
73 ±
67 ±
75 ±
86 ±
151 ±
147 ±
473
22.54
7.55
13.58
7.7X
23.43
26.50
MI
0
0
0
0
1
2.1
0
NM
NM
NM
NM
NM
MN
V
2 x 10"
2 x 10"
2 x lü"
10"
2 x 10"
2 x 10"
3 x 10*
Legend as Tablc 111.
MMS = mutation in response to methyl melhane sulphonate.
Table XVII. Mmagenic
(a) Wilhoul
Assay Ia
S9 mix
evaluaiion of thiazolidine-i-carboxylic acid
Thiazolidine-4- R
carboxylic
MI
•
0 V
acid (ng/platc)
80
160
320
500
SM
DMSO
MMS
263 ±
359 ±
340 ±
292 ±
122 ±
164 ±
2704
39.60
111.04
66.47
106.29
6.36
8.48
0.8
1.6
1.4
1
1.3
20.7
NM
NM
NM
NM
NM
M4 +
I07
107
I07
107
10'
I07
2 x 106
Assay 11 J
with TAI 02
(b) With S9 mix
Assay 1IJ
Thiazolidine-4- R
carboxylic
MI Q V
acid (/xg/plate)
80
160
320
500
SM
DMSO
MMS
99
131
163
155
80
74
2080
± 5.57
± 17.01
± 36.55
± 7.07
± 19.52
± 18.45
0.3
0.7
1.1
I
0.9
25
NM
NM
NM
NM
NM
M4+/T
I07
107
107
107
107
I07
<I06
Thiazolidine-4- R
carboxylic
MI Q v
acid (/ig/platc)
80
160
320
500
SM
DMSO
2-AA
101
109
101
87
151
147
473
± 26.03
± 4.62
± 19.73
± 20.53
± 23.43
± 26.50
0
0
0
0
1
2.1
NM 2 x 10"
NM 2 x 10"
NM2 x 109
NM2 X 10"
2 x IOM
NM2 x 10"
NM3 x 10*
Legend as Table 111.
MMS = mutation in response to methyl methanc sulphonate.
TA102 and TA104 strains do not reach the stationary phase
after a 14-h incubation period (Barrueco, 1986) and in some cases
it was necessary to count revertants after 5 or 6 days, instead
of 2 days, to observe the mutagenic effect, indicating that these
strains grow slowly in a liquid as well as in a solid médium.
We used cultures from 14 h for both strains and in sprte of
the culture conditions being the same, the bacteria titre changed
in different assays for TA104 (107-2 x 109 viables/mi) and
remained constant for TA102 (107 viabies/ml).
The number of spontaneous revertants is dependen! on the
histidine concentration (Green, 1981; Salmeen and Durison,
1981; Aeschbacher etal., 1983; Anderson etal., -1984);
however, in this study, although the concentration was always
the same, spontaneous reversión varied from one assay to another.
This variation may also be influenced by the copy number of
plasmids in individual cell populations (Levin et al., 1982; Marón
and Ames, 1983).
As regards strain TAI04, the higher the spontaneous reversión,
the higher the captan- and folpet-induced reversión; when
spontaneous reversión was similar, the higher .the number of
bacteria piatcd, the higher the captan- and folpet-induced
reversión. On the other hand, with TA102 strain, the lower the
spontaneous reversión, the higher the captafol-induced reversión.
In order to quantify the mutagenic effect caused by test
chemicals we used mutation Índex and mutagenic potency. The
máximum mutation Índex was 12 for captafol, 7.3 for captan
and 6.3 for folpet. The mutagenic potency, in revertants/nmol,
was 537.64 for captafol, 106.63 for captan and 156.91 for folpet.
Captafol was the most mutagenic compound. Captan and folpet
were very similar.
Captan and folpet • were mutagenic with strains initially
described by Ames that detect mutagens damaging G-C base pairs
(Bridges, 1975; McCann et al., 1975; Ficsor et al., 1977;,Carere
etal., 1978; de Flora, 1978; Moriya etal., 1978; Holfstein
et al., 1979; Rinkus and Legator, 1979; de Flora and Boido,
1980; Shiau etal., 1981; Waters etal., 1982; IARC, 1983; de
Flora et al., 1984; Xu et al., 1984). This effect was confirmed
in our laboratory (Barrueco, 1986). On the other hand, captan
and folpet had positive resultó with TAI04, thus these cpmpounds
also behave like mutagens which induce base-pair substitutions
affecting A-T base pairs. Both compounds were non-mutagenic
with TA102—the only strain with an intact excisión repair
system— indicating that the mutagenic activjty of these com-
pounds involves the production of a DNA lesión which is detect-
able and reparable by the excisión repair system, according to
results of different authors (Bridges et al., 1972; Ficsor et al.,
1978).
Captan and folpet behave similarly, the only differcnce bcíng
the cyclic group: an aromatic ring (phthalimidc) in the case of
folpet and tetrahydrophthalimide in captan. Tetrahydrophthal-
imidc was non-mutagenic. Therefore, the trichloromethylthio
moicty scems to be the one responsible for the attack on the DNA.
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Captan is, howevcr, more toxic than folpet. indicating that the
rest of the molecule. Le. tetrahydrophthalimide or phthalimide,
influences the activity of trichloromethylthio moiety.
Captafol showed only a very weak mutagenic effect and this
was not always observed with TA100 (Kawachi et al., 1980;
Moriya et al.. 1983). This effect was not confirmed in our
laboratory (Barrueco, 1986). By using TA102 strain the
mutagenicity of captafol was clearly shown. Captafol was non-
mutagenic with TA104. If the structures of captan and captafol
are compared, their cyclic groups are scen to be idéntica!, i.e.
tetrahydrophthalimide, and the compounds differ in the reactive
moiety, which is trichloromethylthio for captan and tetrachloro-
ethylthio for captafol. Both compounds were mutagenic, so both
reactive groups seem to be responsible for the attack on the DNA,
although their mechanism of action seems to be different. Captafol
was the most toxic compound of all those evaluated, and it
therefore seems probable that captafol causes more serious
damage to DNA than captan or folpet by acting as a crosslinking
agent. Thus, the presence of an intact excisión repair system in
TA102 decreases the toxicity of captafol, allowing the detection
of its mutagenic effect.
Dichlofluanid showed only a véry weak mutagenic effect which
was not always observed with TA100 (Shirasu etal., 1977;
Schupan et al., 1981; Moriya et al., 1983; Schuphan and Casida,
1983). This effect was not confirmed in our laboratory (Barrueco,
1986) and there was no mutagenic response with either TA102
or TAI04 strains. Dichlofluanid has a reactive group similar to
that of captan and folpet in which a chlorine has been substituted
by a fluorine. Schuphan et al. (1981) found that dichlofluanid
and two of its metabolites—thiazolidine-2-thione-4-carboxylic acid
and £/j-(fluorodichloromethyl)disulfíde—were non-mutagenic to
TA100. However, the chlorinated derivative of dichlofluanid was
mutagenic to TA100 (Schuphan and Casida, 1983). Everything,
therefore, seems to point to the fluorine atom as the cause of
the absence of mutagenicity of dichlofluanid. In addition,
dichlofluanid was the second most toxic compound after captafol
and it is again the fluorine atom which appears as the cause of
this toxicity which would prevent the detection of any possible
mutagenic effect.
This study has shown that it is necessary to include strains
TAI04 and TAI02 together with those strains initially used in
the Ames test in order to increase the confidence of detecting
mutagens and shedding light on their mechanism of action.
The mutagenicity of these compounds has also been evaluated
in different derivatives of Escherichia coli WP2 (Bridges, 1975).
These strains carry an ochre mutation at a trp locus and can revert
by structural gene mutations that include transitions at an A-T
base pair or by the formation of ochre suppressors that include
transitions at a G-C base pair. It was found that both types of
mutation were induced in these strains although with differing
proportions and it was necessary to perform another assay with
T4 ochre mutant phage in order to establish the mutational
specificity of these compounds. However, using a set of
Salmonella typhimurium strains wc can establish the mutational
specificity of these compounds without performing another
complementary assay. We thus conclude that Salmonella
typhimurium strains are preferablc to Escherichia coli strains for
the detection of chcmicals in this class.
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